Paper Details

  1. Home
  2. Paper Details

[Pravastatin and acetylsalycilic acid fixed-combination: a strategy to improve cardiovascular outcomes].

Author: HennekensCharles

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This meta-analysis demonstrated the significant reduction in cardiovascular risk in coronary patients treated with combined pravastatin-acetylsalicylic acid therapy.
Paper Details　
Original Abstract of the Article :
The rationale behind combined statin-acetylsalicylic acid therapy is based on the beneficial effects ofacetylsalicylic acid on thrombosis, the leading immediate cause of the majority of occlusive cardiovascular events, and those of statins on atherosclerosis, which is the main underlying cause. The ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF03262467

データ提供：米国国立医学図書館（NLM）

A Powerful Partnership: Pravastatin and Acetylsalicylic Acid in Cardiovascular Health

Cardiovascular disease (CVD), like a relentless desert sandstorm, can threaten our hearts and vessels. This study explores the potential benefits of combining pravastatin, a statin drug that lowers cholesterol, and acetylsalicylic acid (ASA), an antiplatelet drug, in managing CVD. The researchers reviewed five randomized clinical trials and found that the combination therapy significantly reduced the risk of fatal or non-fatal myocardial infarction, ischemic stroke, and other cardiovascular events. This finding suggests that the combined therapy acts like a powerful duo, working together to protect the heart and blood vessels from the ravages of CVD.

A Powerful Duo: Combating CVD with Pravastatin and ASA

This research highlights the potential benefits of combining pravastatin and ASA in managing CVD. It's like a powerful duo, two camels working together to navigate a vast desert, protecting each other from the hazards of the journey. The study's findings suggest that the combined therapy offers significant protection against CVD, reducing the risk of heart attacks, strokes, and other cardiovascular events.

A Desert Oasis: Protecting Cardiovascular Health

This study offers valuable insights into the potential benefits of combining pravastatin and ASA in managing CVD. It's like discovering a hidden oasis in the vast desert of cardiovascular health, providing a safe haven and offering protection from the hazards of this condition. The study's findings encourage the use of this combined therapy as a powerful tool in combating CVD.

Dr. Camel's Conclusion

This research underscores the potential benefits of combining pravastatin and ASA in managing CVD. It's like finding a powerful duo, two camels working together to navigate a vast desert, protecting each other from the hazards of the journey. The study's findings suggest that the combined therapy offers significant protection against CVD, reducing the risk of heart attacks, strokes, and other cardiovascular events.
Date :
  1. Date Completed 2009-11-16
  2. Date Revised 2019-11-11
Further Info :

Pubmed ID

19839182

DOI: Digital Object Identifier

10.1007/BF03262467

Related Literature

Article Analysis
・Effective treatment of statins
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.